Literature DB >> 20495440

Interferon-alpha drives monocyte gene expression in chronic unsuppressed HIV-1 infection.

Hans Rempel1, Bing Sun, Cyrus Calosing, Satish K Pillai, Lynn Pulliam.   

Abstract

OBJECTIVES: HIV-1 infection dysregulates the innate immune system and alters leukocyte-gene expression. The objectives were two fold: to characterize the impact of HIV-1 infection on peripheral monocyte gene expression and to identify the predominant factor(s) responsible for altered gene expression. DESIGN AND METHODS: In a cross-sectional study (n = 55), CD14 monocytes were isolated from 11 HIV-1 seronegative controls, 22 HIV-1 seropositive individuals with low-viral loads (LVL) and 22 HIV-1 seropositive individuals with high-viral loads (HVL). Monocyte gene expression data were collected for control, LVL and HVL individuals using high-density microarrays. We evaluated three HIV-1 disease-related peripheral factors, interferon (IFN)-alpha, IFN-gamma and lipopolysaccharide (LPS) as candidates causing monocyte dysregulation, by comparing gene expression profiles between study individuals and monocytes treated with these factors in vitro. Plasma from HIV-1 positive individuals was quantified for LPS and soluble CD14.
RESULTS: Monocytes from HIV-1-infected individuals with viral loads above 10,000 RNA copies/ml (HVL) displayed an activated phenotype. Characterization of gene expression revealed an ongoing immune response to viral infection including inflammation and chemotaxis. Gene expression analysis of in-vitro-treated HIV-1 seronegative monocytes with IFN-alpha, IFN-gamma or LPS demonstrated that IFN-alpha most accurately recapitulated the HIV-1 HVL profile. No LPS-induced gene expression signature was detected even in HIV-1 individuals with the highest LPS and sCD14 levels.
CONCLUSION: Monocyte gene expression in individuals with HIV-1 viremia is predominantly due to IFN-alpha, whereas individuals with LVL have a nonactivated phenotype. In monocytes, there was no discernible expression profile linked to LPS exposure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20495440      PMCID: PMC2991092          DOI: 10.1097/QAD.0b013e32833ac623

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  35 in total

Review 1.  Interferons in the persistence, pathogenesis, and treatment of HIV infection.

Authors:  M L Francis; M S Meltzer; H E Gendelman
Journal:  AIDS Res Hum Retroviruses       Date:  1992-02       Impact factor: 2.205

Review 2.  LPS induction of gene expression in human monocytes.

Authors:  M Guha; N Mackman
Journal:  Cell Signal       Date:  2001-02       Impact factor: 4.315

3.  Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients.

Authors:  V Soumelis; I Scott; F Gheyas; D Bouhour; G Cozon; L Cotte; L Huang; J A Levy; Y J Liu
Journal:  Blood       Date:  2001-08-15       Impact factor: 22.113

4.  Interferons and interferon (IFN)-inducible protein 10 during highly active anti-retroviral therapy (HAART)-possible immunosuppressive role of IFN-alpha in HIV infection.

Authors:  E Stylianou; P Aukrust; K Bendtzen; F Müller; S S Frøland
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

5.  Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection.

Authors:  M von Sydow; A Sönnerborg; H Gaines; O Strannegård
Journal:  AIDS Res Hum Retroviruses       Date:  1991-04       Impact factor: 2.205

6.  Bioconductor: open software development for computational biology and bioinformatics.

Authors:  Robert C Gentleman; Vincent J Carey; Douglas M Bates; Ben Bolstad; Marcel Dettling; Sandrine Dudoit; Byron Ellis; Laurent Gautier; Yongchao Ge; Jeff Gentry; Kurt Hornik; Torsten Hothorn; Wolfgang Huber; Stefano Iacus; Rafael Irizarry; Friedrich Leisch; Cheng Li; Martin Maechler; Anthony J Rossini; Gunther Sawitzki; Colin Smith; Gordon Smyth; Luke Tierney; Jean Y H Yang; Jianhua Zhang
Journal:  Genome Biol       Date:  2004-09-15       Impact factor: 13.583

Review 7.  Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex.

Authors:  Mitsuhiro Fujihara; Masashi Muroi; Ken-ichi Tanamoto; Tsuneo Suzuki; Hiroshi Azuma; Hisami Ikeda
Journal:  Pharmacol Ther       Date:  2003-11       Impact factor: 12.310

Review 8.  Emerging concepts in the immunopathogenesis of AIDS.

Authors:  Daniel C Douek; Mario Roederer; Richard A Koup
Journal:  Annu Rev Med       Date:  2009       Impact factor: 13.739

9.  Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial.

Authors:  H C Lane; V Davey; J A Kovacs; J Feinberg; J A Metcalf; B Herpin; R Walker; L Deyton; R T Davey; J Falloon
Journal:  Ann Intern Med       Date:  1990-06-01       Impact factor: 25.391

10.  CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract.

Authors:  Jason M Brenchley; Timothy W Schacker; Laura E Ruff; David A Price; Jodie H Taylor; Gregory J Beilman; Phuong L Nguyen; Alexander Khoruts; Matthew Larson; Ashley T Haase; Daniel C Douek
Journal:  J Exp Med       Date:  2004-09-13       Impact factor: 14.307

View more
  47 in total

1.  Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo.

Authors:  Satish K Pillai; Mohamed Abdel-Mohsen; John Guatelli; Mark Skasko; Alexander Monto; Katsuya Fujimoto; Steven Yukl; Warner C Greene; Helen Kovari; Andri Rauch; Jacques Fellay; Manuel Battegay; Bernard Hirschel; Andrea Witteck; Enos Bernasconi; Bruno Ledergerber; Huldrych F Günthard; Joseph K Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

2.  A peripheral monocyte interferon phenotype in HIV infection correlates with a decrease in magnetic resonance spectroscopy metabolite concentrations.

Authors:  Lynn Pulliam; Hans Rempel; Bing Sun; Linda Abadjian; Cyrus Calosing; Dieter J Meyerhoff
Journal:  AIDS       Date:  2011-09-10       Impact factor: 4.177

3.  Microbial translocation: a marker of advanced HIV-1 infection and a predictor of treatment failure?

Authors:  Edana Cassol; Theresa Rossouw; Chris Seebregts; Sharon Cassol
Journal:  J Infect Dis       Date:  2011-01-28       Impact factor: 5.226

4.  Is microbial translocation a cause or consequence of HIV disease progression?

Authors:  Andrew D Redd; Ronald H Gray; Thomas C Quinn
Journal:  J Infect Dis       Date:  2011-01-10       Impact factor: 5.226

5.  Differential effects of HIV viral load and CD4 count on proliferation of naive and memory CD4 and CD8 T lymphocytes.

Authors:  Sharat Srinivasula; Richard A Lempicki; Joseph W Adelsberger; Chiung-Yu Huang; Joshua Roark; Philip I Lee; Adam Rupert; Randy Stevens; Irini Sereti; H Clifford Lane; Michele Di Mascio; Joseph A Kovacs
Journal:  Blood       Date:  2011-05-11       Impact factor: 22.113

Review 6.  Type I interferon signaling, regulation and gene stimulation in chronic virus infection.

Authors:  Sabelo Lukhele; Giselle M Boukhaled; David G Brooks
Journal:  Semin Immunol       Date:  2019-05-30       Impact factor: 11.130

7.  SLAMF7 Is a Critical Negative Regulator of IFN-α-Mediated CXCL10 Production in Chronic HIV Infection.

Authors:  Patrick O'Connell; Yuliya Pepelyayeva; Maja K Blake; Sean Hyslop; Robert B Crawford; Michael D Rizzo; Cristiane Pereira-Hicks; Sarah Godbehere; Linda Dale; Peter Gulick; Norbert E Kaminski; Andrea Amalfitano; Yasser A Aldhamen
Journal:  J Immunol       Date:  2018-12-10       Impact factor: 5.422

8.  Persistent immune activation in chronic HIV infection: do any interventions work?

Authors:  Reena Rajasuriar; Gabriela Khoury; Adeeba Kamarulzaman; Martyn A French; Paul U Cameron; Sharon R Lewin
Journal:  AIDS       Date:  2013-05-15       Impact factor: 4.177

9.  HIV-1 infection induces strong production of IP-10 through TLR7/9-dependent pathways.

Authors:  Rachel P Simmons; Eileen P Scully; Erin E Groden; Kelly B Arnold; J Judy Chang; Kim Lane; Jeff Lifson; Eric Rosenberg; Douglas A Lauffenburger; Marcus Altfeld
Journal:  AIDS       Date:  2013-10-23       Impact factor: 4.177

10.  Tat engagement of p38 MAP kinase and IRF7 pathways leads to activation of interferon-stimulated genes in antigen-presenting cells.

Authors:  Nayoung Kim; Sami Kukkonen; Maria Del Pilar Martinez-Viedma; Sumeet Gupta; Anna Aldovini
Journal:  Blood       Date:  2013-03-27       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.